235 related articles for article (PubMed ID: 20132919)
1. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.
Vincent AL; Ciacci-Zanella JR; Lorusso A; Gauger PC; Zanella EL; Kehrli ME; Janke BH; Lager KM
Vaccine; 2010 Mar; 28(15):2782-7. PubMed ID: 20132919
[TBL] [Abstract][Full Text] [Related]
2. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
[TBL] [Abstract][Full Text] [Related]
3. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
Gauger PC; Vincent AL; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA
Vaccine; 2011 Mar; 29(15):2712-9. PubMed ID: 21310191
[TBL] [Abstract][Full Text] [Related]
4. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
[TBL] [Abstract][Full Text] [Related]
5. Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates.
Kitikoon P; Vincent AL; Janke BH; Erickson B; Strait EL; Yu S; Gramer MR; Thacker EL
Vaccine; 2009 Dec; 28(2):523-31. PubMed ID: 19837089
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
[TBL] [Abstract][Full Text] [Related]
7. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus.
Loeffen WL; de Vries RP; Stockhofe N; van Zoelen-Bos D; Maas R; Koch G; Moormann RJ; Rottier PJ; de Haan CA
Vaccine; 2011 Feb; 29(8):1545-50. PubMed ID: 21219983
[TBL] [Abstract][Full Text] [Related]
10. Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09.
Said A; Lange E; Beer M; Damiani A; Osterrieder N
Virus Res; 2013 May; 173(2):371-6. PubMed ID: 23333290
[TBL] [Abstract][Full Text] [Related]
11. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model.
Laurie KL; Carolan LA; Middleton D; Lowther S; Kelso A; Barr IG
J Infect Dis; 2010 Oct; 202(7):1011-20. PubMed ID: 20715930
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
[TBL] [Abstract][Full Text] [Related]
13. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
[TBL] [Abstract][Full Text] [Related]
14. An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine.
Babiuk S; Masic A; Graham J; Neufeld J; van der Loop M; Copps J; Berhane Y; Pasick J; Potter A; Babiuk LA; Weingartl H; Zhou Y
Vaccine; 2011 Apr; 29(17):3118-23. PubMed ID: 21382482
[TBL] [Abstract][Full Text] [Related]
15. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
Baras B; de Waal L; Stittelaar KJ; Jacob V; Giannini S; Kroeze EJ; van den Brand JM; van Amerongen G; Simon JH; Hanon E; Mossman SP; Osterhaus AD
Vaccine; 2011 Mar; 29(11):2120-6. PubMed ID: 21238573
[TBL] [Abstract][Full Text] [Related]
16. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
[TBL] [Abstract][Full Text] [Related]
17. Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.
Kitikoon P; Vincent AL; Jones KR; Nilubol D; Yu S; Janke BH; Thacker BJ; Thacker EL
Vet Microbiol; 2009 Nov; 139(3-4):235-44. PubMed ID: 19595522
[TBL] [Abstract][Full Text] [Related]
18. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
Kyriakis CS; Gramer MR; Barbé F; Van Doorsselaere J; Van Reeth K
Vet Microbiol; 2010 Jul; 144(1-2):67-74. PubMed ID: 20116942
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
Kappes MA; Sandbulte MR; Platt R; Wang C; Lager KM; Henningson JN; Lorusso A; Vincent AL; Loving CL; Roth JA; Kehrli ME
Vaccine; 2012 Jan; 30(2):280-8. PubMed ID: 22067263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
